Person · CIK 1352620
CIK 1352620
Fetching the filing list from SEC EDGAR. This page refreshes on its own.
Recent filings so far
9 recent filings already on SEC Tracker. The full history, totals and holdings follow when the read from SEC EDGAR finishes.
| Filed | Form | Company | Summary |
|---|---|---|---|
| 2026-11-02 | 4 | Aspen Neuroscience, Inc. (ASPE) | Faheem Hasnain (Executive Chair) converted 36,349 ASPE |
| 2026-10-29 | 3 | Hasnain Faheem (ASPE) | Aspen Neuroscience reports ownership changes |
| 2026-08-26 | 4 | Gossamer Bio, Inc. (GOSS) | |
| 2026-06-04 | 4 | Kura Oncology, Inc. (KURA) | |
| 2026-03-20 | 4 | Gossamer Bio, Inc. (GOSS) | |
| 2026-01-05 | 4 | Gossamer Bio, Inc. (GOSS) | |
| 2025-12-10 | 4 | Kura Oncology, Inc. (KURA) | |
| 2025-12-09 | 144 | Kura Oncology, Inc. (KURA) | |
| 2025-10-02 | 4 | Gossamer Bio, Inc. (GOSS) |
Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.